While most discussions around GLP-1 receptor agonists focus on digestive changes, an increasing number of individuals are reporting skin sensitivity or skin pain. This post covers why this happens, how to identify it, and what you can do to manage these sensations
In contrast, other studies have observed considerably decreased PON 1 in the presence of clinical symptoms [216, 217] and in patients with severe preeclampsia [216]
Where an alternative glucose lowering therapy needs to be considered, use the principles of shared decision making as per NICE guidelines Where there is reduced access to GLP-1 RAs, support people with type 2 diabetes to access to structured education and weight management programmes where available Order stocks sensibly in line with demand during this time, limiting prescribing to minimise risk to the supply chain whilst acknowledging the needs of the patient
10.3390/nano9030387 97
Terms and pricing are subject to change
Nature 555 , 121125 (2018)
